Study design: Randomized multicenter trial.
Randomized multicenter trial in patients who successfully passed a spontaneous breathing trial.
The PRAGUE-15 trial is designed as an open, prospective, randomized multicenter trial comparing RDN versus intensified medical treatment in patients with resistant hypertension.
Methods: In this prospective, randomized, multicenter trial, patients who successfully completed a spontaneous breathing trial were randomized to direct extubation (Control group) or reconnection to the ventilator for a one-hour rest before extubation (Rest group).
Radiation dosimetry studies were performed in patients with non-Hodgkin's lymphoma (NHL) treated with 90Y Zevalin™ (90yttrium ibritumomab tiuxetan, IDEC-Y2B8) on a Phase III open-label prospectively randomized multicenter trial.
We describe the organization of a prospective, randomized, multicenter trial comparing the effectiveness of open popliteal artery aneurysm repair (OPAR) and endovascular popliteal artery aneurysm repair (EPAR) of asymptomatic popliteal artery aneurysms (PAAs) as an example for how to use the Vascular Quality Initiative (VQI) framework.
Between February 2001 and November 2003, 270 patients (180 men and 90 women) were recruited in a phase III, open-label, randomized, multicenter trial conducted by the DITTO-HCV study group at 9 centers in France, Germany, Greece, Israel, Italy, Netherlands, Spain, Sweden, and Switzerland, as previously reported [21].
A prospective, randomized, multicenter trial.
FACE is a phase IIIb open-label, randomized, multicenter trial [ 30].
The RAMBO trial (Radial Head – Amsterdam – Amphia – Boston - Others) is an international prospective, randomized, multicenter trial.
